The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.
Nitric Oxide-Mediated Histone Hyperacetylation in Oral Cancer: Target for a Water-Soluble HAT Inhibitor, CTK7A
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Rarely, some nonreactive, aggregating compounds like CTK7A can produce new spectral peaks independent of DTT (Figure 5) (Arif et al., 2010) (JL Dahlin & KM Nelson et al., in review).”
From ALARM NMR for HTS Triage and Chemical Probe Validation (2018) · cites this paper as Arif et al., 2010
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Anticancer activities of histone deacetylase inhibitors
Bolden, J. E., Peart, M. J., & Johnstone, R. W. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd2133 · Cited by 2,919 · cited 1×
“Dysfunction of HDACs and the consequent hypoacetylation of histone and nonhistone proteins have been causally related to cancer manifestation in a few cases (Bolden et al., 2006).”
BackgroundThe polycomb group protein EZH2 is involved in progression of prostate cancer
Varambally, S., Dhanasekaran, S. M., Zhou, M., Barrette, T. R., Kumar-Sinha, C., Sanda, M. G., Ghosh, D., Pienta, K. J., Sewalt, R. G. A. B., Otte, A. P., et al. (2002) · Nature · doi:10.1038/nature01075 · Cited by 2,717
CBP/p300 in cell growth, transformation, and development
Goodman, R. H., & Smolik, S. (2000) · Genes & Development · doi:10.1101/gad.14.13.1553 · Cited by 1,778 · cited 2×
“…Cell Proliferation and Induces Senescence-like Growth Arrest Because p300/CBP is a master regulator and is involved in the regulation of cell cycle progression, proliferation, and differentiation (Goodman and Smolik, 2000), we next investigated the growth-inhibitory properties of CTK7A on KB cells.”
BackgroundRegulation of the p300 HAT domain via a novel activation loop
Thompson, P. R., Wang, D., Wang, L., Fulco, M., Pediconi, N., Zhang, D., An, W., Ge, Q., Roeder, R. G., Wong, J., et al. (2004) · Nature Structural & Molecular Biology · doi:10.1038/nsmb740 · Cited by 423
Research works printed but not linked: 47
- Altenberg, 2004, Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes, Genomics, 84, 1014, 10.1016/j.ygeno.2004.08.010 · DOI · Paper page
- Anand, 2008, Biological activities of curcumin and its analogues (Congeners) made by man and Mother Nature, Biochem. Pharmacol., 76, 1590, 10.1016/j.bcp.2008.08.008 · DOI · Paper page
- Asano, 1994, Constitutive and inducible nitric oxide synthase gene expression, regulation, and activity in human lung epithelial cells, Proc. Natl. Acad. Sci. USA, 91, 10089, 10.1073/pnas.91.21.10089 · DOI · Paper page
- Bai, 2008, Overexpression of myocyte enhancer factor 2 and histone hyperacetylation in hepatocellular carcinoma, J. Cancer Res. Clin. Oncol., 134, 83, 10.1007/s00432-007-0252-7 · DOI
- Balasubramanyam, 2004, Curcumin, a novel p300/CREB-binding protein-specific inhibitor of acetyltransferase, represses the acetylation of histone/nonhistone proteins and histone acetyltransferase-dependent chromatin transcription, J. Biol. Chem., 279, 51163, 10.1074/jbc.M409024200 · DOI · Paper page
- Bandyopadhyay, 2002, Down-regulation of p300/CBP histone acetyltransferase activates a senescence checkpoint in human melanocytes, Cancer Res., 62, 6231
- Bhaumik, 2007, Covalent modifications of histones during development and disease pathogenesis, Nat. Struct. Mol. Biol., 14, 1008, 10.1038/nsmb1337 · DOI · Paper page
- Black, 2006, A mechanism for coordinating chromatin modification and preinitiation complex assembly, Mol. Cell, 23, 809, 10.1016/j.molcel.2006.07.018 · DOI · Paper page
- Carrozza, 2003, The diverse functions of histone acetyltransferase complexes, Trends Genet., 19, 321, 10.1016/S0168-9525(03)00115-X · DOI · Paper page
- Cole, 2008, Chemical probes for histone-modifying enzymes, Nat. Chem. Biol., 4, 590, 10.1038/nchembio.111 · DOI · Paper page
- Czesnikiewicz-Guzik, 2008, NADPH oxidase and uncoupled nitric oxide synthase are major sources of reactive oxygen species in oral squamous cell carcinoma. Potential implications for immune regulation in high oxidative stress conditions, J. Physiol. Pharmacol., 59, 139
- Davidson, 2005, The transcriptional coactivator p300 plays a critical role in the hypertrophic and protective pathways induced by phenylephrine in cardiac cells but is specific to the hypertrophic effect of urocortin, ChemBioChem, 6, 162, 10.1002/cbic.200400246 · DOI
- Das, 2009, CBP/p300-mediated acetylation of histone H3 on lysine 56, Nature, 459, 113, 10.1038/nature07861 · DOI · Paper page
- Debes, 2003, p300 in prostate cancer proliferation and progression, Cancer Res., 63, 7638
- Dimri, 2005, What has senescence got to do with cancer?, Cancer Cell, 7, 505, 10.1016/j.ccr.2005.05.025 · DOI · Paper page
- Esteller, 2007, Cancer epigenomics: DNA methylomes and histone-modification maps, Nat. Rev. Genet., 8, 286, 10.1038/nrg2005 · DOI · Paper page
- Fraga, 2005, Loss of acetylation at Lys16 and trimethylation at Lys20 of histone H4 is a common hallmark of human cancer, Nat. Genet., 37, 391, 10.1038/ng1531 · DOI · Paper page
- Fukumura, 2006, The role of nitric oxide in tumour progression, Nat. Rev. Cancer, 6, 521, 10.1038/nrc1910 · DOI · Paper page
- Gallo, 1998, Role of nitric oxide in angiogenesis and tumor progression in head and neck cancer, J. Natl. Cancer Inst., 90, 587, 10.1093/jnci/90.8.587 · DOI · Paper page
- Gayther, 2000, Mutations truncating the EP300 acetylase in human cancers, Nat. Genet., 24, 300, 10.1038/73536 · DOI · Paper page
- Grisendi, 2006, Nucleophosmin and cancer, Nat. Rev. Cancer, 6, 493, 10.1038/nrc1885 · DOI · Paper page
- Hansson, 2009, The transcriptional coactivator MAML1 regulates p300 autoacetylation and HAT activity, Nucleic Acids Res., 37, 2996, 10.1093/nar/gkp163 · DOI
- Hara, 2005, S-nitrosylated GAPDH initiates apoptotic cell death by nuclear translocation following Siah1 binding, Nat. Cell Biol., 7, 665, 10.1038/ncb1268 · DOI · Paper page
- Huang, 2005, Akt phosphorylation of p300 at Ser-1834 is essential for its histone acetyltransferase and transcriptional activity, Mol. Cell. Biol., 25, 6592, 10.1128/MCB.25.15.6592-6602.2005 · DOI · Paper page
- Ishihama, 2007, Expression of HDAC1 and CBP/p300 in human colorectal carcinomas, J. Clin. Pathol., 60, 1205, 10.1136/jcp.2005.029165 · DOI · Paper page
- Jenkins, 1994, Human colon cancer cell lines show a diverse pattern of nitric oxide synthase gene expression and nitric oxide generation, Br. J. Cancer, 70, 847, 10.1038/bjc.1994.409 · DOI
- Kouzarides, 2007, Chromatin modifications and their function, Cell, 128, 693, 10.1016/j.cell.2007.02.005 · DOI · Paper page
- Mantelingu, 2007, Specific inhibition of p300-HAT alters global gene expression and represses HIV replication, Chem. Biol., 14, 645, 10.1016/j.chembiol.2007.04.011 · DOI · Paper page
- Moncada, 1991, Nitric oxide: physiology, pathophysiology and pharmacology, Pharmacol. Rev., 43, 109, 10.1016/S0031-6997(25)06663-3 · DOI · Paper page
- Morimoto, 2008, The dietary compound curcumin inhibits p300 histone acetyltransferase activity and prevents heart failure in rats, J. Clin. Invest., 118, 868
- Ota, 2006, Sirt1 inhibitor, Sirtinol, induces senescence-like growth arrest with attenuated Ras-MAPK signaling in human cancer cells, Oncogene, 25, 176, 10.1038/sj.onc.1209049 · DOI · Paper page
- Pfister, 2008, The histone acetyltransferase hMOF is frequently downregulated in primary breast carcinoma and medulloblastoma and constitutes a biomarker for clinical outcome in medulloblastoma, Int. J. Cancer, 122, 1207, 10.1002/ijc.23283 · DOI · Paper page
- Ravindra, 2009, Inhibition of lysine acetyltransferase KAT3B/p300 activity by a naturally occurring hydroxynaphthoquinone, plumbagin, J. Biol. Chem., 284, 24453, 10.1074/jbc.M109.023861 · DOI
- Rouaux, 2003, Critical loss of CBP/p300 histone acetylase activity by caspase-6 during neurodegeneration, EMBO J., 22, 6537, 10.1093/emboj/cdg615 · DOI · Paper page
- Sambucetti, 1999, Histone deacetylase inhibition selectively alters the activity and expression of cell cycle proteins leading to specific chromatin acetylation and antiproliferative effects, J. Biol. Chem., 274, 34940, 10.1074/jbc.274.49.34940 · DOI · Paper page
- Seligson, 2005, Global histone modification patterns predict risk of prostate cancer recurrence, Nature, 435, 1262, 10.1038/nature03672 · DOI · Paper page
- Selvi, 2009, Reversible acetylation of chromatin: implication in regulation of gene expression, disease and therapeutics, Biotechnol. J., 4, 375, 10.1002/biot.200900032 · DOI
- Sen, 2008, Nitric oxide-induced nuclear GAPDH activates p300/CBP and mediates apoptosis, Nat. Cell Biol., 10, 866, 10.1038/ncb1747 · DOI · Paper page
- Shandilya, 2009, Acetylated NPM1 localizes in the nucleoplasm and regulates transcriptional activation of genes implicated in oral cancer manifestation, Mol. Cell. Biol., 29, 5115, 10.1128/MCB.01969-08 · DOI
- Shim, 2002, Hydrazinocurcumin, a novel synthetic curcumin derivative, is a potent inhibitor of endothelial cell proliferation, Bioorg. Med. Chem., 10, 2439, 10.1016/S0968-0896(02)00116-5 · DOI
- Shim, 2004, A new curcumin derivative, HBC, interferes with the cell cycle progression of colon cancer cells via antagonization of the Ca2+/calmodulin function, Chem. Biol., 11, 1455, 10.1016/j.chembiol.2004.08.015 · DOI
- Swaminathan, 2005, Human histone chaperone nucleophosmin enhances acetylation-dependent chromatin transcription, Mol. Cell. Biol., 25, 7534, 10.1128/MCB.25.17.7534-7545.2005 · DOI · Paper page
- Szebeni, 1999, Nucleolar protein B23 has molecular chaperone activities, Protein Sci., 8, 905, 10.1110/ps.8.4.905 · DOI · Paper page
- Thorne, 2009, Transcription factors, chromatin and cancer, Int. J. Biochem. Cell Biol., 41, 164, 10.1016/j.biocel.2008.08.029 · DOI
- Turnell, 2005, The APC/C and CBP/p300 cooperate to regulate transcription and cell-cycle progression, Nature, 438, 690, 10.1038/nature04151 · DOI
- Van Beekum, 2007, Aberrant forms of histone acetyltransferases in human disease, Subcell. Biochem., 41, 233
- Zhou, 2004, Insulin regulation of hepatic gluconeogenesis through phosphorylation of CREB-binding protein, Nat. Med., 10, 633, 10.1038/nm1050 · DOI
Cited by
The yin and yang of nitric oxide in cancer progression
Burke, A. J., Sullivan, F. J., Giles, F. J., & Glynn, S. A. (2013) · Carcinogenesis · doi:10.1093/carcin/bgt034 · Cited by 370
Role of Epigenetics in Inflammation-Associated diseases
Shanmugam, M. K., & Sethi, G. (2013) · Subcellular Biochemistry · doi:10.1007/978-94-007-4525-4_27 · Cited by 141
Crosstalk between nitric oxide and hypoxia-inducible factor signaling pathways: an update
Poyton, R., & Hendrickson, M. (2015) · Research and Reports in Biochemistry · doi:10.2147/rrbc.s58280 · Cited by 45
ALARM NMR for HTS Triage and Chemical Probe Validation
Dahlin, J. L., Cuellar, M., Singh, G., Nelson, K. M., Strasser, J. M., Rappe, T., Xia, Y., Veglia, G., & Walters, M. A. (2018) · Current Protocols in Chemical Biology · doi:10.1002/cpch.35 · Cited by 25
Metadata
- Authors
- Arif, M., Vedamurthy, B. M., Choudhari, R., Ostwal, Y. B., Mantelingu, K., Kodaganur, G. S., & Kundu, T. K.
- Venue
- Chemistry & Biology
- Publisher
- Elsevier BV
- Published
- 2010-08
- Volume
- 17
- Issue
- 8
- Pages
- 903-913
- ISSN
- 1074-5521
- Cited by
- 119
- References
- 4
- Language
- en
- Licence
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- www.elsevier.com/legal/tdmrep-license (tdm)
- www.elsevier.com/open-access/userlicense/1.0/ (vor, 1117 d)
- Funders
- Jawaharlal Nehru Centre for Advanced Scientific Research
- Department of Biotechnology, Government of West Bengal
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.